212 related articles for article (PubMed ID: 33937050)
21. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
23. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
24. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
26. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
27. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.
Zhao M; Li X; Chen X
J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
29. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.
Li C; Wan Y; Deng W; Fei F; Wang L; Qi F; Zheng Z
Open Med (Wars); 2022; 17(1):96-112. PubMed ID: 35028418
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
Wang XJ; Gao J; Wang Z; Yu Q
Front Cell Dev Biol; 2021; 9():641840. PubMed ID: 33681226
[TBL] [Abstract][Full Text] [Related]
31. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
Xue H; Sun Z; Wu W; Du D; Liao S
Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
[TBL] [Abstract][Full Text] [Related]
32. Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
Song J; Liang K; Wei T; Li L; Huang Z; Chen G; Mao N; Yang J
Comb Chem High Throughput Screen; 2023; 26(12):2226-2237. PubMed ID: 36752296
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
34. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
35. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
36. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
Fei H; Chen S; Xu C
Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
39. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
